title: Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis.
authors.affiliation: Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Kevin N
authors.initials: KN
authors.lastname: Christensen
authors.forename: Christine U
authors.initials: CU
authors.lastname: Lee
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Hanley
authors.forename: Nelson
authors.initials: N
authors.lastname: Leung
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Moyer
authors.forename: Mark R
authors.initials: MR
authors.lastname: Pittelkow
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle; D016022:Case-Control Studies; D003287:Contrast Media / Q000493:pharmacokinetics*; D005260:Female; D005682:Gadolinium / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D013058:Mass Spectrometry / Q000379:methods; D008875:Middle Aged; D054989:Nephrogenic Fibrosing Dermopathy / Q000097:blood* / Q000000981:diagnostic imaging / Q000473:pathology; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D012016:Reference Values; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000000981:diagnostic imaging / Q000473:pathology; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012867:Skin / Q000187:drug effects* / Q000378:metabolism; D012869:Skin Absorption / Q000187:drug effects
chemical_list: D003287:Contrast Media; D005682:Gadolinium